China, Aug. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Evaluation of the Safety and Biodistribution Imaging of ⁶⁸Ga-TRD4425 and Low-Dose ¹⁷⁷Lu-TRD4425 in Participants with GRPR (+) Solid Tumors'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130182
Registration Time: 2026/08/17
Type: Interventional study
Primary Sponsor: Guangdong Second Provincial General Hospital (Guangdong Provincial Emergency Hospital)
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338611
Published by HT Digital Content Services with permission from Health Daily Digest....